Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Board/Management Information 2021

Dec 28, 2021

30528_rns_2021-12-28_3851e9a4-e866-4d86-a0af-aa400b7f0ca8.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [452 x 127] intentionally omitted <==

December 28, 2021

The Secretary BSE Limited National Stock Exchange of India Ltd. New York Stock Exchange Inc. NSE IFSC Ltd.

Dear Sir/Madam,

Sub : Board Meeting

Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate you that a meeting of the Board of Directors of the Company will be held on Friday, January 28, 2022, inter alia , to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ending on December 31, 2021.

Further, kindly note that, under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will be closed from Friday, December 31, 2021 to Sunday, January 30, 2022 (both days inclusive).

This is for your information.

With regards,

VIVEK Digitally signed by VIVEK MITTAL MITTAL Date: 2021.12.28 11:00:45 +05'30'

Vivek Mittal Global General Counsel and Compliance Officer